Install
FirstWord
- 112articles · 30d
- 7+ hour agolatest article
- Aug 17, 2026earliest in window
- 0%with images
- 13avg words
- Medical 92
- Health 75
- Health & Wellness 68
- Business & Industrial 39
- Economy, Business & Finance 25
- Finance & Business 16
- Science & Technology 10
- News 4
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
WCLC26: GSK's ris-rez cuts death risk 54% in China Phase III lung cancer trial
15+ hour, 6+ min ago (16+ words) FirstWord Pharma...
Friday Five??? Novartis' stumbles spark boardroom backlash, Nodthera name drops, FDA throws wrench into Biohaven deal???and more
3+ day, 6+ hour ago (19+ words) Friday Five – Novartis' stumbles spark boardroom backlash, Nodthera name drops, FDA throws wrench into Biohaven deal…and more firstwordpharma.com...
Takeda's R&D head Andy Plump to retire after back-to-back approvals
3+ day, 8+ hour ago (13+ words) FirstWord PHARMA...
Schr??dinger forms I&I-focused newco with NEA, RA Capital
4+ day, 4+ hour ago (11+ words) Schrödinger forms I&I-focused newco with NEA, RA Capital FirstWord PHARMA...
Inhibrx touts HNSCC subgroup data, eyes accelerated pathway for OX40 agonist
5+ day, 6+ hour ago (13+ words) FirstWord Pharma...
Physician Views Preview: How are prescribing patterns changing in COPD?
5+ day, 1+ hour ago (12+ words) FirstWord Pharma...
Amgen claims win for Imdelltra in maintenance lung cancer setting
5+ day, 12+ hour ago (12+ words) FirstWord PHARMA...
Roivant's pulmonary hypertension drug mosliciguat scores mid-stage win
5+ day, 20+ hour ago (10+ words) FirstWord Pharma...
Novartis??? Avidity-sourced del-desiran stumbles in Phase III myotonic dystrophy study
5+ day, 22+ hour ago (12+ words) Novartis’ Avidity-sourced del-desiran stumbles in Phase III myotonic dystrophy study FirstWord Pharma...
Physician Views Preview: Can AstraZeneca's Etcamah carve out a new treatment paradigm in breast cancer?
6+ day, 17+ hour ago (17+ words) FirstWord Pharma...